Author: Shah, Sunish; Ackley, Tyler W.; Topal, Jeffrey E.
Title: Renal and Hepatic Toxicity Analysis of Remdesivir Formulations: Does What Is on the Inside Really Count? Cord-id: uvu3kaq0 Document date: 2021_9_17
ID: uvu3kaq0
Snippet: It has been postulated that the injectable solution formulation of remdesivir could be more nephrotoxic than the lyophilized powder since it contains twice as much sulfobutylether-β-cyclodextrin (SBECD). Therefore, we evaluated 1,000 hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who received remdesivir lyophilized powder or solution. A logistic regression model accounting for baseline confounders identified that neither the use of the injectable solutio
Document: It has been postulated that the injectable solution formulation of remdesivir could be more nephrotoxic than the lyophilized powder since it contains twice as much sulfobutylether-β-cyclodextrin (SBECD). Therefore, we evaluated 1,000 hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who received remdesivir lyophilized powder or solution. A logistic regression model accounting for baseline confounders identified that neither the use of the injectable solution (odds ratio [OR], 1.05; 95% confidence interval [CI], 0.49 to 2.29; P = 0.901) nor a creatinine clearance of <30 ml/min at the time of remdesivir initiation (OR, 1.39; 95% CI, 0.51 to 3.5; P = 0.499) was significantly associated with acute kidney injury. Regarding hepatoxicity, there was no significant difference in early discontinuation of remdesivir due to abnormal liver function tests between patients who received the lyophilized powder versus those who received solution (0.9% versus 2.3%, P = 0.09).
Search related documents:
Co phrase search for related documents- abnormal lft and acute respiratory syndrome coronavirus: 1
- abnormal lft and liver function: 1, 2, 3, 4, 5, 6, 7
- abnormal lft and liver function test: 1, 2, 3, 4
- abnormal lfts and acute aki kidney injury: 1
- abnormal lfts and acute respiratory syndrome: 1, 2, 3, 4
- abnormal lfts and acute respiratory syndrome coronavirus: 1, 2, 3, 4
- abnormal lfts and administration remdesivir: 1
- abnormal lfts and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- abnormal lfts and liver function test: 1, 2, 3
- abnormal liver function and acute aki kidney injury: 1
- abnormal liver function and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver function and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- abnormal liver function and administration remdesivir: 1
- abnormal liver function and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver function and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- abnormal liver function test and acute respiratory syndrome: 1, 2, 3
- abnormal liver function test and acute respiratory syndrome coronavirus: 1, 2, 3
- abnormal liver function test and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9
- abnormal liver function test and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date